EBITDA (Quarterly)

EBITDA: Income before interest, taxes, depreciation and amortization.

Fresenius Medical Care AG & Co. KGaA (FMS) had EBITDA of $960.27M for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$5.65B
Net Income	$253.91M
Cost of Goods Sold	$4.13B
Gross Profit	$1.52B
Operating Expenses	$5.11B
Operating Income	$541.65M
Non-Operating Income/Expense	$-96.34M
Pre-Tax Income	$445.31M
Normalized Pre-Tax Income	$445.31M
Income after Taxes	$340.87M
Income from Continuous Operations	$340.87M
Consolidated Net Income/Loss	$340.87M
Normalized Income after Taxes	$340.87M
EBIT	$541.65M
EBITDA	$960.27M
Weighted-Average Shares Outstanding (Basic)	536.88M
Weighted-Average Shares Outstanding (Diluted)	536.88M
Earnings per Share (EPS) (Basic)	$0.47
Earnings per Share (EPS) (Diluted)	$0.47
Balance Sheet Financials
Current Assets	$8.94B
Property, Plant, and Equipment	$4.12B
Long-Term Assets	$27.44B
Total Assets	$36.38B
Current Liabilities	$8.35B
Long-Term Debt	$6.77B
Long-Term Liabilities	$12.31B
Total Liabilities	$20.65B
Common Equity	$15.73B
Tangible Shareholders Equity	$-2.00B
Shareholders Equity	$15.73B
Common Shares Outstanding	532.22M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.26B
Cash Flow from Investing Activities	$-511.87M
Cash Flow from Financial Activities	$-1.40B
Beginning Cash	$1.86B
End Cash	$1.23B
Increase/Decrease in Cash	$-625.37M
Stock-Based Compensation	--
Common Stock Dividends Paid	$-651.04M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.07
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.30
Debt to Equity Ratio	0.56
Gross Margin	26.95%
Operating Margin	9.58%
EBIT Margin	9.58%
EBITDA Margin	--
Pre-Tax Profit Margin	7.88%
Profit Margin	4.49%
Free Cash Flow	$773.01M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.16
Inventory Turnover	1.52
Receiveable Turnover	1.40
Days Sales in Receivables	64.16
Return on Equity	2.17%
Return on Tangible Equity	-17.08%
Return on Assets	0.94%
Return on Investments	1.51%
Book Value Per Share	$29.56
Free Cash Flow per Share	$1.44
Operating Cash Flow per Share	$2.35

Data from Zacks Investment Research, Inc.